Blauvelt A, Bagel J, Pinter A, Thaci D, et al. Repeated switching between biosimilar ABP 654 and reference ustekinumab in patients with moderate-to-severe plaque psoriasis: a randomized, double-blinded clinical trial to support interchangeability. Br J Dermatol 2026 May 29:ljag218. doi: 10.1093.
PMID: 42212408